GlassScriptPhysician profile
Brent A Richardson
NPI 1689780751
$15,118.65
in general payments reported to CMS, 2019-2025
35 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $756 · 2021: $943 · 2022: $1,530 · 2023: $4,350 · 2024: $4,405 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,641 · Travel and Lodging: $3,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,640.58 |
| Travel and Lodging | $3,428.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,732.57 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Saluda Medical Americas, INC. | $3,424.19 | 2023-2025 | Evoke, Evoke Scs |
| Relievant Medsystems, INC. | $2,117.76 | 2022-2023 | Intracept |
| Nevro Corp. | $1,708.88 | 2019-2024 | Senza |
| Abbott Laboratories | $602.86 | 2021-2025 | Eterna, Proclaim |
| Painteq LLC | $600.63 | 2022-2024 | Painteq |
| Medtronic, INC. | $386.18 | 2022-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Abbvie INC. | $350.46 | 2023-2025 | |
| Globus Medical, INC. | $282.37 | 2025 | Senza |
| Pfizer INC. | $251.99 | 2020-2021 | |
| Vertos Medical, INC. | $249.84 | 2021-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $213.25 | 2019-2025 | Belbuca, Xtampza |
| Nalu Medical, INC. | $190.62 | 2021-2024 | Nalu Neurostimulation System |
| Biohaven Pharmaceuticals, INC. | $135.45 | 2021 | |
| Vertiflex, INC. | $98.12 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $97.63 | 2019-2021 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Arbor Pharmaceuticals, INC. | $85.98 | 2019-2022 | |
| Bioventus LLC | $83.48 | 2019-2023 | Durolane |
| Azurity Pharmaceuticals, INC. | $50.06 | 2023-2025 | Horizant, Horizant |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Assertio Therapeutics, INC. | $37.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.32 | 2025 | Relistor |
| Kaleo, INC. | $34.58 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.82 | 2025 | |
| Daiichi Sankyo INC. | $22.33 | 2019 | |
| Bausch Health US, LLC | $21.24 | 2019 | |
| Mdd US Operations, LLC | $19.96 | 2019 | |
| Supernus Pharmaceuticals, INC. | $19.81 | 2019 | |
| Fidia Pharma USA INC. | $19.52 | 2019 | |
| Grt US Holding, INC. | $18.69 | 2020 | |
| Biotronik Nro, INC. | $17.41 | 2025 | Prospera |
| Si-Bone, INC. | $16.59 | 2024 | |
| Lilly USA, LLC | $14.19 | 2019 | |
| Sentynl Therapeutics, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.